Cell BioEngines Licenses Patent for Allogeneic
Small molecule-mediated expansion of engraftable cord-blood derived hematopoietic stem cells (HSC) to address donor availability for allogenic...
Source: globenewswire.com
Stay updated with breaking news from Zev Gechtman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Small molecule-mediated expansion of engraftable cord-blood derived hematopoietic stem cells (HSC) to address donor availability for allogenic...
BOSTON and NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc. is strengthening its Intellectual Property portfolio with a patent licensed from the Icahn School of Medicine at